# NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

> **NCT05136755** · PHASE2 · RECRUITING · sponsor: **China Medical University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** NMDAE
- **DRUG:** Placebo Cap

## Key facts

- **NCT ID:** NCT05136755
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-25
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05136755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05136755, "NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05136755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*